Published in Radiology on June 01, 1999
Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology (2008) 3.47
Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab (2009) 2.43
Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2009) 2.15
MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. Neuroimage (2010) 1.74
Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study. Int J Radiat Oncol Biol Phys (2010) 1.59
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol (2012) 1.38
Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI. NMR Biomed (2011) 1.30
Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology (2004) 1.30
Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology (2010) 1.28
Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res (2014) 1.28
Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology (2007) 1.23
Neuroimaging in neuro-oncology. Neurotherapeutics (2009) 1.22
The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol (2012) 1.18
Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol (2009) 1.14
MR-visible lipids and the tumor microenvironment. NMR Biomed (2011) 1.13
Correlation of MR perfusion imaging and vessel tortuosity parameters in assessment of intracranial neoplasms. Technol Cancer Res Treat (2004) 1.13
The promise of dynamic contrast-enhanced imaging in radiation therapy. Semin Radiat Oncol (2011) 1.12
High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle. J Cereb Blood Flow Metab (2013) 1.11
Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology (2006) 1.10
Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol. Radiology (2011) 1.06
Utility of multiparametric 3-T MRI for glioma characterization. Neuroradiology (2013) 1.06
Preoperative subtyping of meningiomas by perfusion MR imaging. Neuroradiology (2008) 1.05
Perfusion MR imaging for differentiation of benign and malignant meningiomas. Neuroradiology (2008) 1.01
Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours. Br J Radiol (2011) 1.00
Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol (2002) 0.99
Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability. Eur Radiol (2005) 0.98
Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches. Magn Reson Med (2008) 0.97
Modern brain tumor imaging. Brain Tumor Res Treat (2015) 0.97
Imaging tumour angiogenesis. Cancer Imaging (2005) 0.96
Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomas. Neuro Oncol (2014) 0.92
Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas. Neuroradiology (2003) 0.91
Perfusion-weighted magnetic resonance imaging of the brain: techniques and application in children. Eur Radiol (2003) 0.91
Signal intensity in T2' magnetic resonance imaging is related to brain glioma grade. Eur Radiol (2010) 0.90
Measurement of choroid plexus perfusion using dynamic susceptibility MR imaging: capillary permeability and age-related changes. Neuroradiology (2013) 0.90
Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology (2006) 0.89
Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neurooncol (2013) 0.88
Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol (2013) 0.88
Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods. PLoS One (2013) 0.87
Imaging hypoxia in gliomas. Br J Radiol (2011) 0.87
Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors. Neuroradiology (2006) 0.87
High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review. Eur Radiol (2010) 0.86
The application of MRI for depiction of subtle blood brain barrier disruption in stroke. Int J Biol Sci (2010) 0.86
Perfusion imaging of the brain using Z-score and dynamic images obtained by subtracting images from before and after contrast injection. Korean J Radiol (2004) 0.85
ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol (2015) 0.84
Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J Radiol (2001) 0.84
Brain tumor evaluation and segmentation by in vivo proton spectroscopy and relaxometry. MAGMA (2005) 0.83
Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma. J Neurooncol (2013) 0.83
Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model. PLoS One (2013) 0.83
Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma. AJNR Am J Neuroradiol (2015) 0.83
Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas. J Neuroimaging (2015) 0.83
Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging. Korean J Radiol (2015) 0.82
Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach. Neuroradiology (2014) 0.82
Magnetic resonance perfusion imaging in neuro-oncology. Cancer Imaging (2008) 0.82
Perfusion-sensitive MRI of pilocytic astrocytomas: initial results. Neuroradiology (2007) 0.82
Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. AJNR Am J Neuroradiol (2007) 0.81
MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy. Pediatr Radiol (2003) 0.81
Correlation between arterial blood volume obtained by arterial spin labelling and cerebral blood volume in intracranial tumours. MAGMA (2011) 0.81
The striate sign: peritumoural perfusion pattern of infiltrative primary and recurrent gliomas. Neurosurg Rev (2010) 0.80
Quantitative MR perfusion parameters related to survival time in high-grade gliomas. Eur Radiol (2013) 0.80
A two-stage model for in vivo assessment of brain tumor perfusion and abnormal vascular structure using arterial spin labeling. PLoS One (2013) 0.80
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging. J Nucl Med (2015) 0.80
Clinical and research applications of simultaneous positron emission tomography and MRI. Br J Radiol (2013) 0.79
Supervised pattern recognition for the prediction of contrast-enhancement appearance in brain tumors from multivariate magnetic resonance imaging and spectroscopy. Artif Intell Med (2008) 0.78
Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy. CNS Oncol (2014) 0.78
Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases. Neuroradiol J (2016) 0.77
Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics. Neuroradiology (2007) 0.75
Comparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors. PLoS One (2016) 0.75
The role of 4D CT angiography for preoperative screening in patients with intracranial tumors. Neuroradiol J (2016) 0.75
Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma. Sci Rep (2016) 0.75
Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation. AJNR Am J Neuroradiol (2016) 0.75
Susceptibility Imaging in Glial Tumor Grading; Using 3 Tesla Magnetic Resonance (MR) System and 32 Channel Head Coil. Pol J Radiol (2017) 0.75
Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area. Biomed Res Int (2014) 0.75
Molecular Imaging Using Endogenous Cellular Proteins. Bo Pu Xue Za Zhi (2013) 0.75
Early Cerebral Blood Volume Changes Predict Progression After Convection-Enhanced Delivery of Topotecan for Recurrent Malignant Glioma. World Neurosurg (2015) 0.75
Dynamic contrast-enhanced MR imaging. Cancer Imaging (2000) 0.75
Advanced MRI manifestations of trigeminal ganglioneuroma: a case report and literature review. BMC Cancer (2016) 0.75
Measurement of arteriolar blood volume in brain tumors using MRI without exogenous contrast agent administration at 7T. J Magn Reson Imaging (2016) 0.75
Arterial input function and gray matter cerebral blood volume measurements in children. J Magn Reson Imaging (2015) 0.75
Vascular Reactivity Maps in Patients with Gliomas Using Breath-Holding BOLD fMRI. J Neuroimaging (2016) 0.75
Neurologic Applications of PET/MR Imaging. Magn Reson Imaging Clin N Am (2017) 0.75
Perfusion imaging of brain gliomas using arterial spin labeling: correlation with histopathological vascular density in MRI-guided biopsies. Neuroradiology (2016) 0.75
Tumours. Neurol Sci (2008) 0.75
MR imaging characteristics of protoplasmic astrocytomas. Neuroradiology (2010) 0.75
Improving lesion detection and visualization: implications for neurosurgical planning and follow-up. Neuroradiology (2007) 0.75
Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas. Eur J Cancer (2017) 0.75
A Population-Based Digital Reference Object (DRO) for Optimizing Dynamic Susceptibility Contrast (DSC)-MRI Methods for Clinical Trials. Tomography (2017) 0.75
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res (1999) 10.65
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science (1999) 9.18
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature (1999) 6.50
Blindness and visual impairment in southern Malawi. Bull World Health Organ (1986) 6.07
An exploration of the sequence of a 2.9-Mb region of the genome of Drosophila melanogaster: the Adh region. Genetics (1999) 5.87
Prediction of bone density from vitamin D receptor alleles. Nature (1994) 5.36
Increased costs and rates of use in the California workers' compensation system as a result of self-referral by physicians. N Engl J Med (1992) 4.65
The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41
Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med (1999) 4.33
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene (2012) 4.30
Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med (1994) 4.20
Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med (1999) 4.17
Spin warp NMR imaging and applications to human whole-body imaging. Phys Med Biol (1980) 4.05
A dual-luciferase reporter system for studying recoding signals. RNA (1998) 3.92
Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A (1993) 3.66
HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int (1994) 3.60
Observations of intergranular stress corrosion cracking in a grain-mapped polycrystal. Science (2008) 3.53
ISOLATION OF TRICHOMONAS VAGINALIS WITH PENICILLIN. Science (1945) 3.45
Genome-wide survey of protein kinases required for cell cycle progression. Nature (2004) 3.40
A simple method for derivation of rate equations for enzyme-catalyzed reactions under the rapid equilibrium assumption or combined assumptions of equilibrium and steady state. J Biol Chem (1968) 3.34
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
Doping graphene with metal contacts. Phys Rev Lett (2008) 3.09
Clinically atypical expression of pathologically typical Lewy-body parkinsonism. Clin Neuropharmacol (1990) 2.96
Primary central nervous system lymphoma. J Neurosurg (1988) 2.75
Language barriers and resource utilization in a pediatric emergency department. Pediatrics (1999) 2.69
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
MR of spinal cord ganglioglioma. AJNR Am J Neuroradiol (1998) 2.63
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology (2011) 2.62
The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell (1997) 2.57
Fat suppression in MR imaging: techniques and pitfalls. Radiographics (1999) 2.56
Three-dimensional grain mapping by x-ray diffraction contrast tomography and the use of Friedel pairs in diffraction data analysis. Rev Sci Instrum (2009) 2.49
Stereotaxic suboccipital transcerebellar biopsy of pontine mass lesions. J Neurosurg (1989) 2.48
AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J (1998) 2.45
Vibrio parahaemolyticus: a potential pathogen from marine sources in Britain. Lancet (1972) 2.39
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N Engl J Med (1988) 2.36
Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med (2001) 2.34
Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in streptococcus pneumoniae. Mol Microbiol (2000) 2.34
Natural history of Bartonella infections (an exception to Koch's postulate). Clin Diagn Lab Immunol (2002) 2.33
Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg (1987) 2.32
The Columbia University single-ion microbeam. Radiat Res (2001) 2.31
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29
Ensemble asteroseismology of solar-type stars with the NASA Kepler mission. Science (2011) 2.28
Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26
Blindness in the developing world. Br J Ophthalmol (1993) 2.26
Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst (1999) 2.25
Tracheal intubation without neuromuscular block in children. Br J Anaesth (1994) 2.21
Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A (1992) 2.20
The long-term follow-up of patients undergoing saphenous vein bypass surgery. Circulation (1974) 2.19
Causes of suppurative keratitis in Ghana. Br J Ophthalmol (1995) 2.17
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery (1994) 2.13
Length distribution of CDRH3 in antibodies. Proteins (1993) 2.12
Pallidotomy in Parkinson's disease. Neurosurgery (1995) 2.10
Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology (2000) 2.08
Relation of Chlorogenic Acid to Scab Resistance in Potatoes. Science (1952) 2.08
Sequential magnetic resonance imaging following stereotactic radiofrequency ventralis lateralis thalamotomy. J Neurosurg (1991) 2.06
Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02
A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) (1975) 2.01
Screening for osteoporosis: what is the role of heel ultrasound? Med J Aust (1996) 2.01
The balance between isoforms of the prickle LIM domain protein is critical for planar polarity in Drosophila imaginal discs. Genes Dev (1999) 1.98
Value of dilute inocula in cultural examination of sputum. Lancet (1965) 1.96
Automatic tracking and digitization of multiple radiopaque myocardial markers. Comput Biomed Res (1991) 1.96
Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail (1999) 1.96
Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int (1994) 1.95
Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol (1987) 1.93
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
The "first generation" of endovascular stent-grafts for patients with aneurysms of the descending thoracic aorta. J Thorac Cardiovasc Surg (1998) 1.90
Tight-binding inhibitors-I. Kinetic behavior. Biochem Pharmacol (1975) 1.89
Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg (1990) 1.88
Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol (2006) 1.87
Implantable transvenous cardioverter-defibrillators. Circulation (1993) 1.87
Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem (2001) 1.86
Intramedullary spinal cord tumors in children under the age of 3 years. J Neurosurg (1996) 1.84
Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther (2000) 1.84
Changes in the structure of wages in the 1980's: an evaluation of alternative explanations. Am Econ Rev (1992) 1.84
Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol (1998) 1.84
Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery (2000) 1.84
Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol (2009) 1.83
Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis (1996) 1.78
White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res (2001) 1.76
Bone mass, lean mass, and fat mass: same genes or same environments? Am J Epidemiol (1998) 1.74
Genetic and environmental influences on total-body and central abdominal fat: the effect of physical activity in female twins. Ann Intern Med (1999) 1.74
Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis (2001) 1.72
Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Neurology (2006) 1.71
Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg (2000) 1.71
Traumatic thoracic aortic aneurysm: treatment with endovascular stent-grafts. Radiology (1997) 1.70
Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol (1996) 1.70
Outlet strut fracture of the Björk-Shiley 60 degrees Convexo-Concave valve: current information and recommendations for patient care. J Am Coll Cardiol (1988) 1.70
A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol (2000) 1.69
MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology (1993) 1.68
Mechanoreceptors in human cruciate ligaments. A histological study. J Bone Joint Surg Am (1984) 1.68
Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.67
Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg (1994) 1.67
Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg (1996) 1.67
Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology (1988) 1.65
Mitral annular size and shape in sheep with annuloplasty rings. J Thorac Cardiovasc Surg (1999) 1.65
Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg (1993) 1.64